logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
21/08/2025
The Ministry of Industry and Information Technology has released the opinions on the mandatory national standard "Regulations on the Purity, Naming and Marking of Jewelry and Precious Metals", with a public notice period from August 22, 2025 to October 20, 2025.
Latest
3 m ago
Zhongji Anruike and Zhonghang You Southern Storage and Transportation cooperate to jointly build a green methanol supply network.
3 m ago
Zhejiang Shibao (01057.HK) uses part of the unused funds raised for cash management.
3 m ago
On August 21, Yunxiang Technology (02488.HK) spent approximately HK$1.9676 million to repurchase 174,000 shares.
3 m ago
According to the result of overseas drug inspection, the National Medical Products Administration issued the "Announcement of the National Medical Products Administration on Suspending the Import Clearance Record of Loratadine Active Pharmaceutical Ingredient by Vasudha Pharm Chem Limited from India" (No. 22 of 2019) on March 20, 2019, deciding to suspend the issuance of import clearance certificate for the product. After Vasudha Pharm Chem Limited has made improvements, they have submitted an application to the National Medical Products Administration for the resumption of the import clearance record of Loratadine active pharmaceutical ingredient and relevant supplementary registration applications. In accordance with the Drug Administration Law of the People's Republic of China and the Regulations for Overseas Inspection Management of Drugs and Medical Devices, the National Medical Products Administration has decided to resume the import of Loratadine active pharmaceutical ingredient (English name: Loratadine) produced by Vasudha Pharm Chem Limited after the relevant supplementary application has been approved.
3 m ago
Announcement of the State Drug Administration on the resumption of the import customs clearance filing for loratadine raw materials by Fast Pharma Company
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.